The charts on this page feature a breakdown of the total annual pay for the top executives at IRONWOOD PHARMACEUTICALS INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. IRONWOOD PHARMACEUTICALS INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. IRONWOOD PHARMACEUTICALS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Peter M. Hecht Ph.D.
Former Chief Executive Officer
Total Cash $1,292,500 Equity $3,842,268 Other $25,348 Total Compensation $5,160,116
Mark G. Currie Ph.D.
Former Senior Vice President, Chief Scientific Officer and President of R&D
Total Cash $727,500 Equity $1,655,649 Other $62,271 Total Compensation $2,445,420
Thomas A. McCourt
President
Total Cash $697,500 Equity $1,419,120 Other $34,002 Total Compensation $2,150,622
Gina Consylman
Chief Financial Officer and Senior Vice President
Total Cash $622,500 Equity $1,284,149 Other $8,040 Total Compensation $1,914,689
William Huyett
Former Chief Operating Officer
Total Cash $697,500 Equity $3,436,767 Other $8,040 Total Compensation $4,142,307
For its 2018 fiscal year, IRONWOOD PHARMACEUTICALS INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Peter M. Hecht Ph.D. CEO Pay $5,160,116 Median Employee Pay $194,750 CEO Pay Ratio 26:1
For its 2018 fiscal year, IRONWOOD PHARMACEUTICALS INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Amy W. Schulman Total Cash $308,722
Andrew Dreyfus Total Cash $301,423
Douglas E. Williams, Ph.D. Total Cash $301,423
Edward P. Owens Total Cash $311,423
Julie H. McHugh Total Cash $311,423
Lawrence S. Olanoff, M.D., Ph.D Total Cash $307,673
Marsha H. Fanucci Total Cash $311,423
Terrance G. McGuire Total Cash $311,388

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.